Reviews of Interest

The Fc Key to Understanding Anti-TIGIT Biology

May 1, 2024

In the Phase 2 CITYSCAPE trial, Tiragolumab, an anti-TIGIT antibody, demonstrated efficacy when combined with Atezolizumab, an anti-PD-L1, compared to Atezolizumab alone for the treatment of non-small cell lung carcinoma. In mouse models, inhibition of both the TIGIT and PD-1 pathways was shown to synergistically function to reinvigorate T cell [READ MORE]

May 5, 2023

April 17, 2024 – Reviews of Interest PMID: 37726402 Anti-cytokine autoantibodies: mechanistic insights and disease associations. Cheng A, Holland SM. Nat Rev Immunol. 2024 Mar;24(3):161-177. doi: 10.1038/s41577-023-00933-2. Epub 2023 Sep 19.PMID: 37726402 Review. This review provides a comprehensive overview of the emerging field of anti-cytokine autoantibodies (ACAA), including their pathological [READ MORE]

COVID-19 special collection

May 5, 2023

COVID-19 special: PMID: 36198912 COVID-19 and cellular senescence. Schmitt CA, Tchkonia T, Niedernhofer LJ, Robbins PD, Kirkland JL, Lee S. Nat Rev Immunol. 2022 Oct 5:1-13. doi: 10.1038/s41577-022-00785-2. Online ahead of print.PMID: 36198912 Free PMC article. Review. PMID: 36631691 Innate immune evasion strategies of SARS-CoV-2. Minkoff JM, tenOever B. Nat Rev Microbiol. [READ MORE]

COVID-19 Special

May 5, 2023

REVIEWS OF INTEREST

April 19, 2021

Reviews of Interest to cytokine biologists. [READ MORE]

COVID-19 special collection

April 19, 2021

Reviews of interest related to COVID-19 and cytokine biology [READ MORE]

Calling all Early Career Researchers! Make Your Plans to Attend Cytokines 2024 / KAI 2024 Today – Invitation to ECR Networking Event!

July 15, 2024

18:00 – 21:00, October 21 (Mon), 2024 at the Spaceshare Samseong COEX Center (close to the meeting venue) Primary Goal: Enhance the Early Career Researchers (ECR) meeting experience by facilitating networking opportunities at the outset, fostering relationships that extend beyond the meeting. Foster interactions between KAI members and Global Members. [READ MORE]

Photo of Article Co-Authors Viejo-Borbolla, Jacobson, and Plückebaum

Discovery of the first IFN-binding protein in herpes viruses reported

July 15, 2024

Viral modulation of type II interferon increases T cell adhesion and virus spread Herpes and poxviruses express viroceptors, viral proteins that bind cytokines and modulate their activity. Until now, all known viroceptors that bind interferon (IFN) have been discovered exclusively in poxviruses and inhibit IFN activity through blocking the cytokine-receptor [READ MORE]

Hotel Scam Alert!!!

July 15, 2024

We have recently become aware of scammers targeting conference attendees. DO NOT provide any personal information or make any payments in response to unsolicited emails. (See examples) Cytokines 2024 | KAI 2024 and our conference hotels will never send emails or place phone calls to individuals to promote specific accommodations. [READ MORE]

Clinical Trials

July 15, 2024

Clinical Trials of interest to cytokine & interferon researchers huCART19-IL18 in NHL/CLL Patients ClinicalTrials.gov ID NCT04684563 Sponsor University of Pennsylvania Information provided by University of Pennsylvania (Responsible Party) Last Update Posted 2024-05-13 Low Dose IL-2 for the Treatment of Crohn’s Disease ClinicalTrials.gov ID NCT04263831 Sponsor Boston Children’s Hospital Information provided [READ MORE]

Vote Now for ICIS Leadership Positions and Best Cytokine of 2024

July 15, 2024

British playwright Tom Stoppard got it right when he said, “It’s not the voting that’s democracy; it’s the counting.” Some of you may recall a few questions about the final results of last year’s “Cytokine Bracket.” The 2024 edition of the King of Pathogens Memorial Cytokine Bracket has resolved those issues. Scan the QR code to vote.

And while you’re at it, if you are an ICIS member take a moment to vote in the ICIS leadership elections. Also on the ballot is a proposal to amend the number and responsibilities of some Standing Committees listed in the Bylaws.

Ballots were emailed to all members on July 1 with a reminder on July 10th, directly from ElectionBuddy.com. If you didn’t receive yours, please contact the ICIS office. [READ MORE]

Photo of Ruth Franklin at the Acropolis in Athens, Greece

Member Highlight: Meet Ruth Franklin

July 15, 2024

My main research interest now is the convergence between immunology and regenerative biology, and thus, the Franklin Lab is focused on understanding the way immune cells contribute to tissue remodeling and repair. The ICIS community has been so warm and welcoming! Being a member of ICIS has given me a [READ MORE]

ICIS Elections: Last Day to Vote is July 31, 2024

July 15, 2024

Each year Members of ICIS are asked to elect members of the governing council and nominations committee. This year, members are also asked to vote on a change to the Bylaws of the Society regarding Standing Committees. These important elections determine the direction and the future of the Society. All [READ MORE]

We are pleased to announce the recipients of the Travel & Achievement Awards for Cytokines 2024 & KAI 2024, congratulations to all those who have been selected!

July 14, 2024

Congratulations!The 2024 ICIS-Pfizer Trainee Award Winners are: Abstract Number Presenting Author Affiliation Country A-0030 Amir Shamshirian QIMR Berghofer Medical Research Institute Australia A-0070 In Hwa Jang University of Minnesota United States A-0084 Benjamin Broomfield The Walter and Eliza Hall Institute (WEHI) Australia A-0450 Eugenio Contreras Castillo National Autonomous University of [READ MORE]

Share this:

Share this:

Share this:

Share this:

Share this:

Share this: